🇺🇸 FDA
Patent

US 7306806

Recombinant P. falciparum merozoite protein-142 vaccine

granted A61KA61K2039/555A61K2039/55555

Quick answer

US patent 7306806 (Recombinant P. falciparum merozoite protein-142 vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/555, A61K2039/55555, A61K2039/55561, A61K2039/55572